32 full factorial design
FORMULATION AND EVALUATION OF DRY NASAL MUCOADHESIVE POWDER OF DESMOPRESSIN ACETATE BY USING 32 FULL FACTORIAL DESIGN
... 2 factorial design was employed using concentration of HPMC (Methocel E5) and feed rate as independent variables and particle size (PS) and % yield were selected as dependent ...using Design Expert ...
18
OPTIMIZATION OF FAST DISSOLVING TABLETS OF PROMETHAZINE THEOCLATE WITH EFFERVESCENT TECHNOLOGY USING 32 FULL FACTORIAL DESIGN
... ABSTRACT: The aim of the research work was to develop and optimize fast dissolving tablets of Promethazine Thecolate by direct compression using effervescent technology. For the investigation, purpose a 32 ...
10
Development of Liquisolid Tablets of Chlorpromazine using 32 Full Factorial Design
... formulations were less than 1 % w/w. All formulations were found to be within USP 32 NF 27 limits as per weight variation test and assay (Table 5). Disintegration time was ranging between 46.33±5.30 to 113.66± ...
8
DEVELOPMENT AND EVALUATION OF FLOATING TABLET CONTAINING NEVIRAPINE USING A 32 FULL FACTORIAL DESIGN OPTIMIZATION METHOD
... Multiple regression and mathematical model was used to develop a floating sustained release system with release retardant polymer and effervescent agent. The polymer compositions with effervescent agent level are ...
6
FORMULATION AND EVALUATION OF FAST DISSOLVING ORAL FILMS OF TERBUTALINE SULPHATE USING 32 FULL FACTORIAL DESIGN
... Fast dissolving films are playing an important role in the current pharmaceutical drug delivery systems. They have convenience and ease of use over solid and liquid dosage forms. In the present research, fast dissolving ...
12
FORMULATION IN-VITRO CHARACTERIZATION AND OPTIMIZATION OF CONTROLLED RELEASE OSMOTIC TABLET OF SITAGLIPTINE USING 32 FULL FACTORIAL DESIGN
... The Present investigation deals with formulation evaluation optimization of controlled release osmotic tablets using 3 2 full factorial experimental design. Nine formulation were formulated according ...
12
Studies on optimization of reservoir-type transdermal patch using carvedilol using 32 full factorial design
... in Factorial Design study: The drug release data of factorial design batches were fitted to kinetic model and the r 2 value were compared ...
6
OPTIMIZATION OF 32 FULL FACTORIAL DESIGN BASED NORFLOXACIN NANOPARTICLES EMBEDDED THERMO SENSITIVE DROPPABLE GEL FOR OCULAR DRUG DELIVERY
... 2 full factorial design as per design expert software ...of design of experiments (DOE), the methodology encompasses the use of various types of experimental designs, generation of ...
29
FORMULATION AND DEVELOPMENT OF BOSENTAN LOADED ONCE A DAILY TABLET FOR PULMONARY ARTERY HYPERTENSION USING LIPID MATRICES BY 32 FULL FACTORIAL DESIGN
... ABSTRACT: To avoid problems of conventional therapy of drug delivery and reduced dose, sustained release matrix tablet of Bosentan was prepared using lipid base material as matrices. Primary screening of polymer was done ...
12
DEVELOPMENT AND OPTIMIZATION OF FAST DISSOLVING TABLETS OF PROMETHAZINE THEOCLATE USING 32 FULL FACTORIAL DESIGN
... The raw materials were passed through a no. 100 screen prior to mixing. Promethazine Thecolate, SSG, crospovidone, microcrystalline cellulose and lactose were mixed using a glass mortar and pestle. The blends were ...
11
FORMULATION AND OPTIMIZATION BY APPLYING 32 FULL FACTORIAL DESIGN OF MUCOADHESIVE MICROSPHERES OF NIFEDIPINE
... the design of drug delivery systems, mucoadhesive microspheres are a contemporary topic of interest to prolong the residence time of the dosage form on the site of application or absorption ...
7
DEVELOPMENT OF ONDANSETRON HCL FAST DISINTEGRATING TABLETS USING 32 FULL FACTORIAL DESIGN
... ABSTRACT: The present investigation was carried out to study the disintegrant property of Plantago ovata and Ocimum basilicum mucilages. The objective of the work was to develop Fast disintegrating tablets of Ondansetron ...
6
Optimization of ex vivo permeability characteristics of berberine in presence of quercetin using 32 full factorial design
... approach was employed to investigate the effect of independent variables such as the concentration of bioenhancer (X 1 ) and pretreatment time (X 2 ) on dependent variable % cumulative drug release (% CDR) (Y) using ...
10
Formulation Optimization of Sustained Release Resinate Microcapsules of Tramadol Hydrochloride by Using 32 Factorial Design
... value less than 0.05. All the other terms were non significant. The Model F-value of 40.68 implies the model is significant. There is only a 0.06% chance that an F-value this large could occur due to noise. The "Pred ...
7
Development of Fast Dissolving Tablets of Bisoprolol Fumarate and Statistical Optimization by Using 32 Factorial Design.
... The slow dissolution of the compressed tablet containing even highly water- soluble ingredients is due to the fact that the low porosity of the tablets reduces water penetration into the matrix. When volatile materials ...
119
FORMULATION AND OPTIMIZATION OF LIQUISOLID TABLETS OF OLMESARTAN MEDOXOMIL USING 32 FACTORIAL DESIGN
... 2 Factorial Design: From the comparative study of carriers, avicel and neusilin, neusilin was selected for further optimization ...2 factorial design was employed for the preparation of the ...
12
32 Factorial Design for Optimization of HPLC-UV Method for Quantification of Gallic acid in Lohasava and Pippalyasava
... Conclusion: Factorial design assisted HPLC method was developed and validated for quantitative determination of gallic acid in two commercial formulations of ...
9
SOLID DISPERSION AN APPROACH TO ENHANCE THE DISSOLUTION RATE OF ACECLOFENAC BY USING 32 FACTORIAL DESIGN
... Solubilization is the process by which the apparent solubility of a poorly water soluble substance is increased. Solubilization techniques include addition of a cosolvent, salt formation, prodrug design, ...
6
FORMULATION DEVELOPMENT AND EVALUATION OF LAMOTRIGINE SUSTAINED RELEASE TABLETS USING 32 FACTORIAL DESIGN
... 2 factorial design in order to select the best combination of different rate retarding polymers, HPMC K4M, HPMC K100M and also to achieve the desired prolong/sustained release of drug from the dosage ...two ...
7
FORMULATION AND EVALUATION OF MOUTH DISSOLVING FILMS OF LOSARTAN POTASSIUM USING 32 FACTORIAL DESIGN
... Preparation of Buccal Film: Films were prepared by solvent casting technique. The required quantity of polymer was accurately weighed and allowed to soak in water for 24 h until it formed a uniform viscous solution. ...
10